ArticleKidney3602026

Correction to: Safety and Efficacy of Tenapanor for Long-term Serum Phosphate Control in Maintenance Dialysis: A 52-Week Randomized Phase 3 Trial (PHREEDOM).

Geoffrey A Block et al.PubMed ↗Publisher ↗

No numbers read from the abstract.